← All indications
Hepatitis, Chronic
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
Subtype terms (4)
More specific conditions that are subtypes of Hepatitis, Chronic in the MeSH hierarchy.
- Hepatitis, Autoimmune
30 drugs (18 approved, 12 experimental)
- Hepatitis B, Chronic
220 drugs (60 approved, 160 experimental)
- Hepatitis C, Chronic
242 drugs (106 approved, 136 experimental)
- Hepatitis D, Chronic
19 drugs (10 approved, 9 experimental)
Drugs by status
Phase 4 trials (8)
Phase 3 trials (3)
Phase 2 trials (4)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (145)
- Bristol-Myers Squibb
- Roche
- Gilead Sciences
- Schering-Plough
- Merck
- Sanofi
- Novartis
- Bukwang Pharmaceutical
- Chugai
- Dong-A Pharmaceutical
- GlaxoSmithKline
- Hannover Clinical Trial Center GmbH
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- MinaPharm Pharmaceuticals
- SciClone Pharmaceuticals
- Shineway Pharmaceutical Co.,Ltd
- Foundation for Liver Research
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- Ain Shams University
- Tzu Chi University
- Cairo University
- Center For Hepatitis C, Atlanta, GA
- Chang Gung University
- Changhua Christian Hospital
- Changi General Hospital
- Chiayi Christian Hospital
- Chung Shan Medical University
- Chungbuk National University
- +115 more
Organization Involved with Phase 3 Indications (91)
- Abivax S.A.
- AbbVie
- Human Genome Sciences
- Serono
- Eisai
- Pharmasset
- Bausch Health Companies
- Vertex
- Debiopharm
- Merck Serono
- Romark
- Ascletis Pharmaceuticals Co., Ltd.
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Institut Pasteur
- Leadiant Biosciences, Inc.
- Toray Industries, Inc
- Xiamen Amoytop Biotech Co., Ltd.
- Xintong Pharmacy Company
- Chong Kun Dang Pharmaceutical
- IlDong Pharmaceutical Co Ltd
- Pharco Pharmaceuticals
- French National Agency for Research on AIDS and Viral Hepatitis
- National Hepatology & Tropical Medicine Research Institute
- National Institute of Allergy and Infectious Diseases (NIAID)
- Ajou University
- Central South University
- Alexandria University
- Azienda Ospedaliera San Camillo Forlanini
- Azienda Ospedaliera V. Cervello
- Campus Bio-Medico University
- +61 more
Organization Involved with Phase 2 Indications (100)
- PPD
- Achillion Pharmaceuticals
- Green Cross Corporation
- AstraZeneca
- Pfizer
- Tibotec
- Alnylam Pharmaceuticals
- Arrowhead Pharmaceuticals
- Anza Therapeutics, Inc.
- Avanti Polar Lipids, Inc.
- BioWest Therapeutics Inc
- Can-Fite BioPharma
- ChronTech Pharma AB
- Cocrystal Pharma, Inc.
- CureTech Ltd
- Digna Biotech S.L.
- FibroGen
- GlobeImmune
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Hepatera Ltd.
- Inovio Pharmaceuticals
- Kyowa Hakko Kirin
- LG
- R-Pharm
- Qilu Pharmaceutical Co., Ltd.
- Santaris Pharma A/S
- Spring Bank Pharmaceuticals, Inc.
- Sunshine Lake Pharma Co., Ltd.
- Teva
- Vaxine Pty Ltd
- +70 more
Organization Involved with Phase 1 Indications (31)
- Ligand Pharmaceuticals
- Ascentage Pharma Group Inc.
- GeneCure Biotechnologies
- Hengrui Therapeutics, Inc.
- Novira Therapeutics, Inc.
- Avid Bioservices
- PowderMed
- Scynexis, Inc.
- Dynavax Technologies Corporation
- Genexine, Inc.
- Pevion Biotech Ltd
- Transition Therapeutics
- National Cancer Institute (NCI)
- Cathay General Hospital
- Temple University
- Institut National de la Santé Et de la Recherche Médicale, France
- Medical University of Warsaw
- Pontificia Universidad Catolica de Chile
- Siriraj Hospital
- University of Nebraska
- City University of Hong Kong
- Maharaj Nakorn Chiang Mai Hospital
- GeneOne Life Science
- Quest Clinical Research
- AIDS Research Consortium of Atlanta
- Orange Coast Medical Center
- Impact Clinical Trials
- Synteract, Inc.
- Nucorion Pharmaceuticals, Inc.
- PharmaEssentia Corp.
- +1 more
Organization Involved with Other Experimental Indications (23)
- Parexel
- United States Army
- Corporal Michael J. Crescenz VA Medical Center
- Triệu, Nguyễn Thị, M.D.
- Aarhus University
- Medical University of Graz
- Changhai Hospital
- Chulalongkorn University
- Hillel Yaffe Medical Center
- Maimonides Medical Center
- Postgraduate Institute of Medical Education and Research
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Sichuan University
- Institute of Liver and Biliary Sciences, India
- Xiamen University
- Zhengzhou University
- Bar Ilan University
- University of Amsterdam
- Tran Minh Duc, Dr.
- Ram Manohar Lohia Insitute of Medical Sciences
- The Swedish Research Council
- The Geneva Foundation
- Government of Punjab, India